Oral, once-daily doses of VYN202 being evaluated in subjects with moderate-to-severe plaque psoriasisTop-line data from the 12-week double-blind ...
Bristol Myers Squibb (BMS) has shared positive five-year results from a long-term extension (LTE) study of its oral TYK2 ...
The European Commission (EC) has approved Biocon Biologics’ Yesintek, an ustekinumab biosimilar referencing Johnson & Johnson’s Stelara, to treat multiple inflammatory diseases.
Oral, once-daily doses of VYN202 being evaluated in subjects with moderate-to-severe plaque psoriasis Top-line data from the 12-week double-blind trial expected by year-end 2025 Phase 1b trial designe ...
There are many misconceptions about psoriasis—and a common one is that it is triggered by bad personal hygiene. However, ...
Dr Grant said: “I recommend keeping a close eye on dry or cracked skin as it can be a telltale sign of psoriasis. Dry skin ...
How one Big Pharma ad campaign is incorporating diversity as a driving force in improving the ways drugs are marketed directly to the patients that need them.
Omega 3 fatty acids are some of the most critical nutrients which help humans remain healthy. They are well known for helping ...
Plaque psoriasis is a chronic immune-mediated disease resulting in overproduction of skin cells, which causes inflamed, scaly plaques that may be itchy or painful. 1 It is estimated that eight million ...
The company aims to soon launch two tests to aid the treatment of dermatomycosis and is developing other tests for healthcare ...
Pinworm causes mild itching in and around the anus ... It is possible to experience psoriasis patches on the butt or groin area. The most common type of psoriasis, plaque psoriasis, presents as thick, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results